In an effort to increase efforts to prevent new infections, the Federal Capital Territory Administration plans to launch Lenacapavir, a new injectable alternative for HIV prevention. In partnership with the FCT Agency for the Control of AIDS and the National AIDS, Viral Hepatitis, and STIs Control Programme, the FCT HIV/AIDS, Viral Hepatitis, and STIs Control Programme is spearheading the rollout, scheduled for Tuesday at Asokoro District Hospital. The FCT Public Health Department revealed this in a press invitation sent to our correspondent on Monday.